cobalt chloride co-57 Report issue

Small molecule Approved FDA
ChEMBL PubChem

Active Ingredient History

NOW
  • Now
Cobaltous chloride CO-57 (or Cobalt 57) is a radioactive compound, decays by electron capture with a physical half-life of 270.9 days. This compound is a part of diagnostic capsules Rubratrope-57, for the diagnosis of pernicious anemia and as a diagnostic adjunct in other defects of intestinal vitamin B12 absorption. Rubratrope-57 was withdrawn in July 2017.   NCATS

Chemistry

More Chemistry

Pharmacology

  • Mechanism of Action:
  • Multi-specific: Missing data
  • Payload: 57-cobalt
  • Black Box: No
  • Availability: Discontinued
  • Delivery Methods: Missing data
  • Pro Drug: No

Alternative names

57co | cobalt chloride (57co) | cobalt chloride co-57 | cobaltous chloride (57co) | cobaltous chloride co 57 | cobatope-57

Organizations (1)

Research & Development (0)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (1)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (1)

Approved Indications (1)


 

Anemia, Pernicious (approved 1970)

Experimental Indications - Clinical Trial Phases 1-4 (0)

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue